Large-scale prospective pharmacogenomics study of oxaliplatin-induced neuropathy in colon cancer patients enrolled in the JFMC41-1001-C2 (JOIN Trial).
about
Large-scale prospective pharmacogenomics study of oxaliplatin-induced neuropathy in colon cancer patients enrolled in the JFMC41-1001-C2 (JOIN Trial).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Large-scale prospective pharma ...... e JFMC41-1001-C2 (JOIN Trial).
@en
Large-scale prospective pharma ...... enrolled in the JFMC41-1001-C2
@nl
type
label
Large-scale prospective pharma ...... e JFMC41-1001-C2 (JOIN Trial).
@en
Large-scale prospective pharma ...... enrolled in the JFMC41-1001-C2
@nl
prefLabel
Large-scale prospective pharma ...... e JFMC41-1001-C2 (JOIN Trial).
@en
Large-scale prospective pharma ...... enrolled in the JFMC41-1001-C2
@nl
P2093
P2860
P356
P1433
P1476
Large-scale prospective pharma ...... e JFMC41-1001-C2 (JOIN Trial).
@en
P2093
A Takagane
H Ishikawa
J Hasegawa
J Sakamoto
K Ishigure
K Shinozaki
P2860
P304
P356
10.1093/ANNONC/MDW074
P577
2016-02-18T00:00:00Z